Dr Reddy's Laboratories Shares Outstanding 2010-2024 | RDY

Dr Reddy's Laboratories shares outstanding for the quarter ending September 30, 2024 were 4.170B, a 400.52% increase year-over-year.

  • Dr Reddy's Laboratories 2024 shares outstanding were 0.834B, a 0.19% increase from 2023.
  • Dr Reddy's Laboratories 2023 shares outstanding were 0.832B, a 0.03% increase from 2022.
  • Dr Reddy's Laboratories 2022 shares outstanding were 0.832B, a 0.01% increase from 2021.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.

Dr Reddy's Laboratories Shares Outstanding 2010-2024 | RDY

  • Dr Reddy's Laboratories 2024 shares outstanding were 0.834B, a 0.19% increase from 2023.
  • Dr Reddy's Laboratories 2023 shares outstanding were 0.832B, a 0.03% increase from 2022.
  • Dr Reddy's Laboratories 2022 shares outstanding were 0.832B, a 0.01% increase from 2021.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Related Stocks
Company NameMarket
Cap
Teva Pharmaceutical Industries (TEVA)$19B
BridgeBio Pharma (BBIO)$4.3B
Bausch Health Cos (BHC)$3B
Amphastar Pharmaceuticals (AMPH)$2.1B
Supernus Pharmaceuticals (SUPN)$2B
Taysha Gene Therapies (TSHA)$434M
Personalis (PSNL)$261M
Assembly Biosciences (ASMB)$98M
Sol-Gel Technologies (SLGL)$12M
Evoke Pharma (EVOK)$7M
Teligent (TLGT)$0M